fixable viability dye efluor™ 780 Search Results


ghost dyetm red 780 fixable viability dye  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc ghost dyetm red 780 fixable viability dye
Ghost Dyetm Red 780 Fixable Viability Dye, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ghost dyetm red 780 fixable viability dye/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
ghost dyetm red 780 fixable viability dye - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
fixable viability dye 780  (Becton Dickinson)
90
Becton Dickinson fixable viability dye 780
Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability <t>Dye</t> <t>780</t> staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.
Fixable Viability Dye 780, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fixable viability dye 780/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
fixable viability dye 780 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
780 nm fluorescent fixable viability dye  (Becton Dickinson)
90
Becton Dickinson 780 nm fluorescent fixable viability dye
Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability <t>Dye</t> <t>780</t> staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.
780 Nm Fluorescent Fixable Viability Dye, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/780 nm fluorescent fixable viability dye/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
780 nm fluorescent fixable viability dye - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
viability dye bd horizontm fixable viability stain 780  (Becton Dickinson)
90
Becton Dickinson viability dye bd horizontm fixable viability stain 780
Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability <t>Dye</t> <t>780</t> staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.
Viability Dye Bd Horizontm Fixable Viability Stain 780, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/viability dye bd horizontm fixable viability stain 780/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
viability dye bd horizontm fixable viability stain 780 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
fixable viability dye efluor 780  (Avantor)
90
Avantor fixable viability dye efluor 780
Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability <t>Dye</t> <t>780</t> staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.
Fixable Viability Dye Efluor 780, supplied by Avantor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fixable viability dye efluor 780/product/Avantor
Average 90 stars, based on 1 article reviews
fixable viability dye efluor 780 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cell-impermeable dna dye bd horizon fixable viability stain 780  (Becton Dickinson)
90
Becton Dickinson cell-impermeable dna dye bd horizon fixable viability stain 780
Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability <t>Dye</t> <t>780</t> staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.
Cell Impermeable Dna Dye Bd Horizon Fixable Viability Stain 780, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell-impermeable dna dye bd horizon fixable viability stain 780/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cell-impermeable dna dye bd horizon fixable viability stain 780 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
fixable viability dye efluor 506  (Thermo Fisher)
90
Thermo Fisher fixable viability dye efluor 506
Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability <t>Dye</t> <t>780</t> staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.
Fixable Viability Dye Efluor 506, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fixable viability dye efluor 506/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
fixable viability dye efluor 506 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
fixable viability dye apc-efluor 780  (Becton Dickinson)
90
Becton Dickinson fixable viability dye apc-efluor 780
Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability <t>Dye</t> <t>780</t> staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.
Fixable Viability Dye Apc Efluor 780, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fixable viability dye apc-efluor 780/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
fixable viability dye apc-efluor 780 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
fixable viability dye efluor 780  (Thermo Fisher)
90
Thermo Fisher fixable viability dye efluor 780
Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability <t>Dye</t> <t>780</t> staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.
Fixable Viability Dye Efluor 780, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fixable viability dye efluor 780/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
fixable viability dye efluor 780 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability Dye 780 staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.

Journal: Materials Today Bio

Article Title: Synergized photothermal therapy and magnetic field induced hyperthermia via bismuthene for lung cancer combinatorial treatment

doi: 10.1016/j.mtbio.2023.100825

Figure Lengend Snippet: Ex-vivo bismuthene immunocompatibility in PBMCs (a) Impact of bismuthene on PBMC viability. PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability Dye 780 staining (BD). Ethanol at 70% was used as a positive control, while samples incubated with medium alone were used as negative controls. Histograms showing live and dead cells as % of positive cells. All the experiments were performed in triplicate and shown as means ± SD (Two-Way ANOVA and student T Test). (b) PBMCs were treated with bismuthene (100 μg/mL) for 24 h or left untreated (Unt), LPS (2 μg/mL) and ConA (10 μg/mL, Sigma) were used as positive controls. Cell activation was evaluated by flow cytometry, PBMCs were gated by specific membrane markers for the two major subpopulations: T cells (CD3-FITC, Clone: UCHT1, BD) and monocytes (CD16 BV711, Clone 3G8, BD). Cells were stained with CD25-PE and CD69-FITC. Cell activation of PBMCs was expressed as % of positive cells. Histogram plots showing positivity for CD25-PE (Clone M-A251, BD) and CD69-BV421 (Clone FN50, BD) staining in PBMCs treated with bismuthene (100 μg/mL) Data are presented as mean ± SD of three independent samples. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (two-way ANOVA). (c) Cytokine production. IL-4, IL-5, IL-6, IL-10, IL-12, TNFα and IFNγ concentration measured in the supernatant of PBMCs treated with bismuthene (100 μg/mL) for 24 h, using BD Cytometric Bead Array(CBA) Kit.

Article Snippet: PBMCs were treated with different concentrations (10, 50, 100 and 200 μg/mL) of bismuthene for 24 h. Cell viability was analyzed by flow cytometry using Fixable Viability Dye 780 staining (BD).

Techniques: Ex Vivo, Flow Cytometry, Staining, Positive Control, Incubation, Activation Assay, Membrane, Concentration Assay